A Randomized Comparative Clinical Trial to assess the efficacy of Thalam with KṣīrabalÄ taila 7 Avarthi and KachÅ«rÄdi cÅ«rna applied over Bregma versus Obelion in acute Grade 1 Hypertension
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 116
- 试验地点
- 1
- 主要终点
- Reduction in Blood pressure
研究概览
简要总结
A Randomized Comparative Clinical trial involving 116 participants with acute Grade 1 hypertension, who will be selected based on European Society of Cardiology Guidelines. The participantswill be randomized into two groups following random number table method. Group A will receive Thalam with KṣīrabalÄ taila (7A) and KachÅ«rÄdi cÅ«rna at Bregma for 45 minutes and Group B will receive Thalam with KṣīrabalÄ taila (7A) and KachÅ«rÄdi cÅ«rna at Obelion for 45 minutes. BP will be assessed according to World Health Organization (WHO) guidelines; before, during (15min, 30min,45min) and after treatment (60min) using digital automatic BP monitor.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
入选标准
- •Grade 1 HTN Gender – no discrimination Participants willing to give informed consent Participants fit for Thalam.
排除标准
- •Grade 2 & 3 HTN Patient taking anti-hypertensive medicine Known case of: Unstable angina, DM, heart and renal failure, liver disease, hyperlipidemia Pregnant and lactating women.
结局指标
主要结局
Reduction in Blood pressure
时间窗: During treatment (15min, 30min, 45min) | After treatment (60min)
次要结局
- Distance from the Nasion to the center of the scalp where the participant’s middle finger touches using a measuring tape, assessed across 100 participants .
研究者
Dr Leena KT
VPSV Ayurveda college